COPENHAGEN (Reuters) - Denmark's health authority said on Wednesday it expects to announce its decision on how to proceed with Johnson & Johnson's COVID-19 vaccine next week pending further investigations into its possible link to rare blood clots.
(Reporting by Nikolaj Skydsgaard; Editing by Andrew Heavens)
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
